FDA Inspection 1060054 — Sharp Drugs, Inc.
The FDA completed an inspection of Sharp Drugs, Inc. on Jul 13, 2018 in Westhampton Beach, NY. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jul 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Westhampton Beach, NY (United States)